ANS Biotech
ANS Biotech is a preclinical contract research organization specializing in pain pharmacology services.
- Company typePrivate
- Founded2006
- HeadquartersRiom, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ANS Biotech does
ANS Biotech specializes in the preclinical pharmacology of pain. They support the drug discovery and development efforts of human and animal health companies. They focus on neurology, gastroenterology, rheumatology, oncology, and surgical therapeutic areas.
ANS Biotech firmographics
Firmographics- Name
- ANS Biotech
- Legal name
- ANS Biotech SA.
- Website
- https://www.ans-biotech.com
- Company type
- Private
- Founded year
- 2006
- Headcount range
- 11–50 employees
- Short description
- ANS Biotech is a preclinical contract research organization specializing in pain pharmacology services.
- Ownership category
- akta.pro rank
ANS Biotech industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industry
- Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)
Keywords
Where ANS Biotech is headquartered
LocationHeadquarters
- HQ city
- Riom
- HQ country
- France
- HQ region
- Europe
Markets served
ANS Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
ANS Biotech product offering
Product offeringCore offering
ANS Biotech is a preclinical contract research organization that delivers specialized pain pharmacology services to pharmaceutical and biotechnology clients. Its work centers on animal models and experimental studies used to evaluate the efficacy and mechanism of action of analgesic and pain-modulating drug candidates prior to clinical development.
Differentiator
Problem solved
Functional benefit
Products and services
- Preclinical Pain Pharmacology Services Contract research services focused on preclinical pain pharmacology studies for pharmaceutical and biotechnology clients developing analgesic and pain-modulating drug candidates.
Companies that use ANS Biotech
Customer profileIdeal customer profiles1 record
ANS Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ANS Biotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Amneal PharmaceuticalscoreZambon Biotech entered into an exclusive licensing agreement with Amneal Pharmaceuticals for IPX203 in the EU, UK, and Switzerland. Amneal Pharmaceuticals is the original developer/licensor of IPX203, and Zambon secured exclusive rights to commercialize the drug in these territories.
Recent moves1 record
Expansion highlights1 record
ANS Biotech competitors and assessment
Company assessmentDirect peers
- Porsolt: French-headquartered preclinical CRO with a comparable niche focus on pain, CNS, and behavioral pharmacology. Highly comparable in scale, geography, and therapeutic-area specialization to ANS Biotech.
- Biotrial: French-headquartered CRO providing preclinical and early clinical research services. Comparable in geography and CRO service profile, with overlap in CNS and pain indications.
Broad incumbents
- Charles River Laboratories: The largest global preclinical CRO, offering safety assessment, discovery, and pain/CNS pharmacology services at scale. Comparable in service category but vastly larger and broader than ANS Biotech.
- Eurofins Scientific: European-headquartered bioanalytical and preclinical CRO/CDMO providing contract research services to pharma and biotech. Comparable as a European contract research provider with preclinical capabilities.
- Evotec: European drug-discovery CRO offering preclinical research and pharmacology services to biopharma sponsors. Comparable in service category and European positioning.
- Pharmaron: Global CRO/CDMO offering preclinical pharmacology, safety assessment, and drug discovery services. Comparable in preclinical CRO capabilities but with much broader scale and geographic reach.
- WuXi AppTec: Global CRO/CDMO providing preclinical research, toxicology, and pharmacology services. Comparable in service category but operates at significantly larger scale across multiple geographies.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
ANS Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
ANS Biotech leadership team
Management profileNumber of profiles
Profiles1 record
ANS Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ANS Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ANS Biotech
What does ANS Biotech do?
ANS Biotech is a preclinical contract research organization that delivers specialized pain pharmacology services to pharmaceutical and biotechnology clients. Its work centers on animal models and experimental studies used to evaluate the efficacy and mechanism of action of analgesic and pain-modulating drug candidates prior to clinical development.
Is ANS Biotech a public or private company?
ANS Biotech is a private company. It is classified as founder individual operated bootstrapped.
When was ANS Biotech founded?
ANS Biotech was founded in 2006. It employs 11 to 50 people.
Where is ANS Biotech based?
ANS Biotech is headquartered in Riom, France, in the Europe region.
Who are ANS Biotech's main competitors?
Direct peers on record are Porsolt and Biotrial. Broad incumbents are Charles River Laboratories, Eurofins Scientific, Evotec, Pharmaron and WuXi AppTec.
Does ANS Biotech have an API?
No public API is recorded for ANS Biotech.
What industry is ANS Biotech in?
ANS Biotech's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals. Its NAICS code is 541714 and its SIC code is 8731.